Law360, New York (September 24, 2009) -- A federal judge has permanently blocked Teva Pharmaceuticals USA Inc. from launching a copy of Eli Lilly & Co.'s blockbuster osteoporosis drug Evista, rejecting Teva's argument that four Lilly patents are invalid.
Judge Sarah Evans Baker of the U.S. District Court for the Southern District of Indiana ruled Wednesday following a bench trial that four of the seven patents asserted by Lilly...
